Groupe La Francaise Bio N Tech Se Transaction History
Groupe La Francaise
- $6.19 Trillion
- Q2 2025
A detailed history of Groupe La Francaise transactions in Bio N Tech Se stock. As of the latest transaction made, Groupe La Francaise holds 4,200 shares of BNTX stock, worth $443,058. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,200
Previous 4,200
-0.0%
Holding current value
$443,058
Previous $418 Million
6.41%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$848 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$446 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$422 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$380 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$200 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...